Patient Awareness of Extra intestinal Manifestations of Inflammatory Bowel Disease in Riyadh, Saudi Arabia

被引:0
|
作者
Aldosari, Mosfer S. [1 ]
AlOtaibi, Fahad F. [1 ]
AlHuzaimi, Abdullah M. [1 ]
Khalil, Noha K. [1 ]
Faden, Nourah A. [1 ]
Thaniah, Salem Y. [2 ]
机构
[1] King Saud Univ, Coll Med, Riyadh, Saudi Arabia
[2] King Saud Univ, Dept Gastroenterol, Riyadh, Saudi Arabia
来源
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND ALLIED SCIENCES | 2018年 / 7卷 / 01期
关键词
Inflammatory bowel disease; Saudi Arabia; Awareness;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Insight into extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) is important to the patient's quality of life and their coping with the disease. Objectives: We investigated the awareness and source of information about EIMs among patients with IBD. Methods: A total of 210 patients [117 (55.7%) males; 93(44.3%) females; age > 18 years] with a diagnosis of IBD were included in this cross-sectional study conducted from July to October 2016 in 3 gastroenterology clinics in Riyadh, Saudi Arabia. Data were collected using a convenience sampling technique and via self-administered questionnaires designed by the investigators. The chi-square test was used for the data analysis. Results: Most respondents were aware of the relation between IBD and at least 1 EIM (81.9%); however, none could identify all 9 EIMs. Most respondents (57.1%) could identify 2 or less EIMs and the EIM least known to them was venous thromboembolism (4.8%). The most recognized complication was colon cancer (53.8%) followed by oral lesions (42.9%). Less than half of the patients were aware of the relation of arthritis, skin lesions, eye inflammation, and osteoporosis with inflammatory bowel disease. Relatively few participants were aware of the relationship of primary sclerosing cholangitis (14.3%), kidney stones (7.6%), and venous thromboembolism (4.8%) with the disease. Conclusions: Patients had high awareness of the common EIMs and complications but revealed poor knowledge of the rare ones, which may be associated with higher morbidity rates. We suggest that these patients be properly educated not only on EIMs with high incidence but also those with low incidence.
引用
收藏
页码:72 / 79
页数:8
相关论文
共 50 条
  • [31] Awareness and attitude of patients toward extra-oral examination in dental practice in Riyadh, Saudi Arabia
    Al Zamel, Ghada
    AlHarbi, Mamdouh
    AlSheraimi, Abdullah
    AlHazmi, Khalid
    AlKubedan, Nawaf
    AlEnezi, Abdulrahman
    MEDICAL SCIENCE, 2020, 24 (104) : 2573 - 2578
  • [32] Prevalence of extra-intestinal manifestations of inflammatory bowel disease in a population-based cohort
    Chalmers-Watson, T. A.
    Tarrant, K. M.
    Barclay, M.
    Shirley, P. M.
    Frampton, C. M. A.
    Gearry, R. B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A221 - A221
  • [33] Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
    Adams, DH
    Eksteen, B
    NATURE REVIEWS IMMUNOLOGY, 2006, 6 (03) : 244 - 251
  • [34] Extra-intestinal Manifestations Are Not Associated With Idiopathic Pancreatitis Among Patients With Inflammatory Bowel Disease
    Pasam, Ravi Teja
    Hoque, Asahi
    Osman, Karim T.
    Farhoud, Adel
    Abdelfattah, Ahmed
    Ramadorai, Vishant
    Chaudrey, Khadija
    Pellish, Randall
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1374 - S1374
  • [35] Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease
    Li, Ying-Chao
    Li, Wei-Zhi
    Wu, Chang-Rui
    Feng, Yun
    Ren, Li
    Mi, Chen
    Li, Yang
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (10) : 1476 - 1479
  • [36] Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease
    David H. Adams
    Bertus Eksteen
    Nature Reviews Immunology, 2006, 6 : 244 - 251
  • [37] AN EXPERT CONSENSUS TO STANDARDIZE DEFINITIONS AND MANAGEMENT FOR EXTRA-INTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
    Falloon, Katherine
    Cohen, Benjamin L.
    Ananthakrishnan, Ashwin
    Barnes, Edward L.
    Bhattacharya, Abhik
    Colombel, Jean Frederic
    Cross, Raymond K.
    Driscoll, Marcia
    Fernandez, Anthony P.
    Ha, Christina
    Herfarth, Hans
    Horst, Sara N.
    Hou, Jason K.
    Husni, M. E.
    Kroshinsky, Daniela
    Kuhn, Kristine A.
    Lowder, Careen Y.
    Martin, George M.
    Parikh, Deep
    Sayed, Christopher J.
    Schocket, Lisa
    Siaton, Bernadette C.
    Vedak, Priyanka
    Weisman, Michael H.
    Rieder, Florian
    GASTROENTEROLOGY, 2022, 162 (07) : S431 - S432
  • [38] Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease
    Ying-Chao Li
    Wei-Zhi Li
    Chang-Rui Wu
    Yun Feng
    Li Ren
    Chen Mi
    Yang Li
    International Journal of Ophthalmology, 2016, (10) : 1476 - 1479
  • [39] The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study
    Ferretti, Francesca
    Monico, Maria Camilla
    Cannatelli, Rosanna
    Carmagnola, Stefania
    Lenti, Marco Vincenzo
    Di Sabatino, Antonio
    Conforti, Francesco
    Pastorelli, Luca
    Caprioli, Flavio
    Bezzio, Cristina
    Saibeni, Simone
    Mazza, Stefano
    Vecchi, Maurizio
    Maconi, Giovanni
    Ardizzone, Sandro
    FRONTIERS IN MEDICINE, 2022, 9
  • [40] Prevalence and risk factors of cytomegalovirus colitis in inflammatory bowel disease patients in Riyadh, Saudi Arabia: A tertiary center experience
    Alotaibi, Yazeed
    Allehibi, Abed
    Almtawa, Abdullah
    Alotaibi, Nawaf
    Alghamdi, Adel
    Alrajhi, Saad
    Alqutub, Adel
    Aleid, Ahmad
    Alamr, Abdulrhman
    Al Ibrahim, Bashaar
    Alahmari, Mohammed
    Alhamidi, Hussam
    Ahmad, Shameem
    Alshammari, Fouad
    Almotawa, Fahad
    Altannir, Youssef
    Alghamdi, Ahmed
    SAUDI JOURNAL OF MEDICINE & MEDICAL SCIENCES, 2023, 11 (04) : 305 - 313